Issue 8/2017
Content (23 Articles)
Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review
Molly Lin, Sujin Park, Anna Hayden, Dean Giustini, Martina Trinkaus, Morris Pudek, Andre Mattman, Marion Schneider, Luke Y.C. Chen
Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
Giovanni Di Minno, David Navarro, Carlo Federico Perno, Mariana Canaro, Lutz Gürtler, James W. Ironside, Hermann Eichler, Andreas Tiede
Central nervous system involvement in adults with haemophagocytic lymphohistiocytosis: a single-center study
Guilan Cai, Yini Wang, Xiaojing Liu, Yanfei Han, Zhao Wang
Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes
Yesica Bestach, Virginia Palau Nagore, María G. Flores, Jacqueline González, Jorge Arbelbide, Nora Watman, Yamila Sieza, Irene Larripa, Carolina Belli
Thromboses and hemorrhages are common in MPN patients with high JAK2V617F allele burden
Irene Bertozzi, Giulia Bogoni, Giacomo Biagetti, Elena Duner, Anna Maria Lombardi, Fabrizio Fabris, Maria Luigia Randi
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios
Giuseppe Saglio, Philipp le Coutre, Jorge Cortes, Jiří Mayer, Philip Rowlings, François-Xavier Mahon, Glenn Kroog, Kyna Gooden, Milayna Subar, Neil P. Shah
Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis
Rafet Eren, Mehmet Hilmi Doğu, Servet Emir, Gülben Erdem Huq, Oğuzhan Okçu, Şermin Altındal, Osman Yokuş, Elif Suyanı
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)
A. García-Noblejas, J. Cannata-Ortiz, E. Conde, E. González Barca, N. Gutiérrez, R. Rojas, M.J. Vidal, M.J. Ramírez, A. Jiménez-Ubieto, J.C. García-Ruiz, J. M. Sancho, A. López, P. Ríos Rull, S. Novelli, C. Albo, G. Debén, A. López-Guillermo, C. Nicolás, S. González de Villambrosia, S. Mercadal, A. Martín García-Sancho, R. Arranz
Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution
Yuhua Huang, Huilan Rao, Shumei Yan, Fang Wang, Qinian Wu, Yanfen Feng, Yujing Zhang
Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience
Mao Li, Yongqian Jia, Juan Xu, Xiaomin Cheng, Caigang Xu
Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemia
Yanmin Zhao, Jiasheng Wang, Yi Luo, Jimin Shi, Weiyan Zheng, Yamin Tan, Zhen Cai, He Huang
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation
Michael Heuser, Razif Gabdoulline, Patrick Löffeld, Vera Dobbernack, Henriette Kreimeyer, Mira Pankratz, Madita Flintrop, Alessandro Liebich, Sabrina Klesse, Victoria Panagiota, Michael Stadler, Martin Wichmann, Rabia Shahswar, Uwe Platzbecker, Christian Thiede, Thomas Schroeder, Guido Kobbe, Robert Geffers, Brigitte Schlegelberger, Gudrun Göhring, Hans-Heinrich Kreipe, Ulrich Germing, Arnold Ganser, Nicolaus Kröger, Christian Koenecke, Felicitas Thol
Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
Volker Wiebking, Sebastian Hütker, Irene Schmid, Stefanie Immler, Tobias Feuchtinger, Michael H. Albert
Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT)
Annekathrin Hilken, Claudia Langebrake, Christine Wolschke, Jan Felix Kersten, Holger Rohde, Peter Nielsen, Nicolaus Kröger
Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes
Qian Li, Changying Luo, Chengjuan Luo, Jianmin Wang, Benshang Li, Lixia Ding, Jing Chen
Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm
Mónica Bernal, Pilar Jiménez, Jose Puerta, Francisco Ruíz-Cabello, Manuel Jurado
Variant of classical high grade PTLD: post-transplant EBV-negative T cell lymphoblastic leukaemia after solid organ transplantation
Kristin Teiken, Hans Kreipe, Britta Maecker-Kolhoff, Kais Hussein
Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement
Chen Tian, Hongliang Yang, Lei Zhu, Qing Zhang, Zeng Cao, Yizhuo Zhang
Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Sweet syndrome secondary to myelodysplastic syndrome mimicking necrotizing fasciitis
Kai Shen, Bing Xiang, Ting Liu
Co-occurrence of type I CALR and two MPL mutations in patient with primary myelofibrosis
Hammad Tashkandi, Erika M. Moore, Benjamin Tomlinson, Teresa Goebel, Navid Sadri
Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia—a single-center observational study
Sofia Jönsson, Bob Olsson, Jenny Söderberg, Hans Wadenvik